This invention relates to a shear and temperature stable antibody formulations that are more stable than compared to a standard formulation (such as 30 mM citrate, 100mM NaCI, pH 6.5). The present invention's shear and temperature stable antibody formulations show reduced precipitation when subjected to stress conditions but the standard formulation had aggregated. This result was unpredictable because thermodynamically the two formulations are similar as seen by their DSC (differential scanning calorimeter) profiles.本發明係關於切變且溫度穩定的抗體配製物,其比標準配製物(例如30mM檸檬酸鹽、100Mm氯化鈉、pH6.5)更為穩定。本發明之切變且溫度穩定之抗體配製物在受到應力狀態時顯示沈澱減少,反之,標準配製物卻聚集一起。由於兩配製物在熱力學上以DSC(示差掃瞄熱量計)態樣極為相似,因此此種結果為不可預期的。